Senior insider sale
Chief Commercial Officer at REVANCE THERAPEUTICS, INC. — senior position signals high conviction
$880.1K
26.02K shares
SJUTS DUSTIN S plans to sell 26.02K shares of REVANCE THERAPEUTICS, INC. valued at approximately $880.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock
Not Applicable
Restricted Stock
Not Applicable
Employee Stock Purchase Plan
Cash
Restricted Stock
Not Applicable
Employee Stock Purchase Plan
Cash
Restricted Stock
Not Applicable
Employee Stock Purchase Plan
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/15/2020 | Restricted Stock Not Applicable | 255.00 | — |
2/15/2020 | Restricted Stock Not Applicable | 545.00 | — |
12/31/2019 | Employee Stock Purchase Plan Cash | 382.00 | — |
12/15/2019 | Restricted Stock Not Applicable | 1.09K | — |
6/30/2019 | Employee Stock Purchase Plan Cash | 1K | — |
4/15/2019 | Restricted Stock Not Applicable | 818.00 | — |
12/31/2018 | Employee Stock Purchase Plan Cash | 910.00 | — |
| Total | 5K | ||
Completed
Units to sell
21.02K
Market value
$726.0K
Planned — Approximate Date
Units to sell
5K
Market value
$154.1K
Units
26.02K
Value
$880.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/15/2023 | 21.02K | $726.0K | — | Completed |
| Planned — Approximate Date | ||||
6/9/2023 | 5K | $154.1K | NASD | Planned |
| Total | 26.02K | $880.1K | ||